Expertise in
16
conditions

Hilario Nunes

Bobigny, FR 
Expertise in
16
conditions
Bobigny, FR 

Overview

Hilario Nunes practices practicing medicine in Bobigny, France.

Mr. Nunes is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Sarcoidosis, and Lung Transplant.

He is actively involved in clinical research, co-authoring 238 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Bobigny, France
Other Locations
Paris, France
Creteil, France
Toulouse, France
Villetaneuse, 93430, France
France
Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Pragmatic Management of Progressive Disease in Idiopathic Pulmonary Fibrosis: a Randomized Trial
Pragmatic Management of Progressive Disease in Idiopathic Pulmonary Fibrosis: a Randomized Trial
Enrollment Status: Completed
Publish Date: February 09, 2026
Intervention Type: Drug
Study Drug: Pirfenidone
Study Phase: Phase 4
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: August 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Randomized Trial of Efficacy and Safety of an Early OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome: a Strategy to Prevent Hospitalization
A Randomized Trial of Efficacy and Safety of an Early OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome: a Strategy to Prevent Hospitalization
Enrollment Status: Withdrawn
Publish Date: April 27, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

238 Total Publications

Occupational category, job type, and sarcoidosis: Findings from a French multicenter study.
Occupational category, job type, and sarcoidosis: Findings from a French multicenter study.
Journal: Pulmonology
Published: June 24, 2026

Frequently Asked Questions about Hilario Nunes

Is Hilario Nunes a top-rated expert for Interstitial Lung Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Hilario Nunes is classified as an Elite expert for Interstitial Lung Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hilario Nunes participate in research or clinical trials?

Yes. Hilario Nunes has published 238 articles and abstracts on conditions like Interstitial Lung Disease. You can view a list of Hilario Nunes's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nunes's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile